GETTING MY RAW MATERIALS TO WORK

“The present problem has exposed some structural weaknesses inside the EU’s medicines source chain and a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides said. She advised that offer chain problems be addressed in an EU pharmaceutical system expected to get released by the top in the yr